Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.35
15.03.21
€34.00
15.03.22
10.85%

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.50
30.11.20
€38.00
30.11.21
4.31%

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
Higher EBIT margin than peer group
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.40
18.11.20
-
18.11.21
4.64%

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.02
22.02.20
€33.21
04.11.21
8.95%

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€83.00
22.12.19
€69.00
04.11.21
-19.15%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€76.60
20.11.19
€85.00
04.11.21
-11.68%

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€235.41
17.01.19
€349.00
04.11.21
49.54%

Could be worthwhile Investment >10% per year